Elevance Health Inc

ELV: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|G#LOCK|^&$@LOCK|%Xx&#pK

Elevance Earnings: Higher 2026 Outlook Mildly Boosts Shares

Elevance reported first-quarter results including 2% revenue growth and adjusted EPS of $12.58, well above FactSet consensus of $11.03, albeit helped by $1 of nonrecurring investment income. The company raised its 2026 adjusted EPS guidance to at least $26.75, up from at least $25.50.

Sponsor Center